Yes Citislicker, agreed - 

In fact in the summary of his comments on Pharma discussions here: https://agoracom.com/ir/Resverlogix/forums/discussion/topics/746450-the-old-boy-who-cried-wolf/?message_id=2281916#message   he has stated clearly that he talks to different potential pharma partners for different indications and/or drug combinations.  

Also - they have already got a partnership with Pfizer for Zenith - so I imagine that discussions actually have been ongoing on all fronts all along. Not sure how extensive they were in past.

But probably picking up since BTD and SGLT2 results. May not have been a bad thng to have waited until RVX had BTD etc. to finalize - somewhat more solid bargaining position.

Am not privy to the list of 4 or 5 that have been following all along - but we know of at least some candidates - people who have come from the board of other large pharma, pharma that is involved in ZEN deals, SGLT-2 manufactuers, etc.

Here's hoping this next trial is a success and that many people will be helped if this ever launches. Preferably sooner than later.